BIOMAT Database Logo BIOMAT Database Logo

Nalidixic acid for shigellosis. 1983

H E Parry

UI MeSH Term Description Entries
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D004405 Dysentery, Bacillary DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest). Shigellosis,Dysentery, Shiga bacillus,Dysentery, Shigella boydii,Dysentery, Shigella dysenteriae,Dysentery, Shigella dysenteriae type 1,Dysentery, Shigella flexneri,Dysentery, Shigella sonnei,Shigella Dysentery,Shigella Infection,Bacillary Dysentery,Dysenteries, Shigella,Dysenteries, Shigella boydii,Dysenteries, Shigella dysenteriae,Dysenteries, Shigella flexneri,Dysenteries, Shigella sonnei,Dysentery, Shigella,Infection, Shigella,Infections, Shigella,Shiga bacillus Dysentery,Shigella Dysenteries,Shigella Infections,Shigella boydii Dysenteries,Shigella boydii Dysentery,Shigella dysenteriae Dysenteries,Shigella dysenteriae Dysentery,Shigella flexneri Dysenteries,Shigella flexneri Dysentery,Shigella sonnei Dysenteries,Shigella sonnei Dysentery
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012764 Shigella sonnei A lactose-fermenting bacterium causing dysentery. Bacterium sonnei

Related Publications

H E Parry
Nalidixic acid for shigellosis.
November 1983, Lancet (London, England),
H E Parry
Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
November 1988, The Journal of pediatrics,
H E Parry
Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
April 1973, Archives of disease in childhood,
H E Parry
Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
February 2001, JPMA. The Journal of the Pakistan Medical Association,
H E Parry
Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
January 1981, Scandinavian journal of infectious diseases,
H E Parry
Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.
April 2004, The Pediatric infectious disease journal,
H E Parry
Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis.
January 1972, Clinical pharmacology and therapeutics,
H E Parry
Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
April 1994, Scandinavian journal of gastroenterology,
H E Parry
Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.
December 2002, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
H E Parry
[Nalidixic acid].
June 1967, Antibiotica,
Copied contents to your clipboard!